-
J&J single-shot COVID-19 vaccine gets Emergency Use Listing by WHO
expresspharma
March 15, 2021
Data have demonstrated vaccine protects against COVID-19 related hospitalisation and death in broad geographic regions, including those with variants of significant concern.
-
Johnson & Johnson announces aingle-ahot Janssen COVID-19 vaccine candidate met primary endpoints in interim analysis of its Phase 3 ENSEMBLE trial
worldpharmanews
March 09, 2021
Johnson & Johnson announced top line efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key ...
-
J&J Announces Single-Shot Janssen COVID-19 Vaccine Candidate Submission to WHO
americanpharmaceuticalreview
February 23, 2021
Johnson & Johnson announced Janssen-Cilag International has submitted for Emergency Use Listing (EUL) to the World Health Organization (WHO) for the investigational single-dose Janssen COVID-19 vaccine candidate.
-
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
prnewswire
February 01, 2021
Johnson & Johnson announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key ...
-
Janssen begins second Phase III Covid-19 vaccine trial
pharmaceutical-technology
November 17, 2020
The Janssen Pharmaceutical Companies of Johnson & Johnson (J&J) has initiated enrolment and dosing of participants in the Phase III ENSEMBLE 2 trial of a two-dose regimen of JNJ-78436735, an investigational vaccine candidate for preventing Covid-19 ...
-
Johnson & Johnson prepares to resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 vaccine candidate in the U.S.
worldpharmanews
October 28, 2020
Johnson & Johnson is preparing to resume recruitment in the pivotal Phase 3 ENSEMBLE trial of its investigational Janssen COVID-19 vaccine in the United States after a temporary pause.
-
J&J Initiates Phase III ENSEMBLE Trial for COVID-19 Vax
contractpharma
September 24, 2020
Will enroll up to 60,000 volunteers across three continents to study the safety and efficacy of a single vaccine dose of JNJ-78436735 versus placebo.
-
Ensemble Invests in Philly’s Navy Yard Life Sciences Hub
contractpharma
September 17, 2020
Ensemble Real Estate Investments has closed on the purchase of three large life sciences facilities occupied by WuXi Advanced Therapies in Philadelphia's Navy Yard.